Cardiology Audit for Patients with ACS and on DAPT (CAP A DAPT)

Background and purpose: Gastrointestinal bleeding is the most common serious complication of long-term antiplatelet use. The ESC DAPT 2017 guide recommends the use of proton pump inhibitors (PPIs) and dual antiplatelet agents (DAPT) as Category 1B recommendations. Our audit aims to ensure that our practices are parallel to international standards. Methods: We prospectively audited 18 patients admitted to NHS hospitals in the UK due to ACS (STEMI, NSTEAC) within 6 weeks from May 2, 2018/2018, 12/03/2018. Therefore, we have launched a new safe discharge summary checklist for ACS patients and team education; A reminder message will appear about the development of the electronic prescription system to consider PPI when prescribing DAPT. One year after implementing the changes, we revisited our action plan. We use the same method; we prospectively reviewed 26 patients with ACS 02/04/2019 01/03/2019.

Author(s): Ahmed Ayuna1

Abstract | PDF

Share This Article